Post-transplant lymphoproliferative disorder

Known as: PTLD, Post-transplant lymphoproliferative disorder (PTLD) 
Post-transplant lymphoproliferative disorder (PTLD) is a polyclonal (benign) or clonal (malignant) proliferation of lymphoid cells that develops as a… (More)
National Institutes of Health

Related topics

Related topics

11 relations
Atypical lymphocyteHematopoietic and Lymphoid CellHematopoietic and Lymphoid TissueImmune System Diseases
(More)

Broader (1)

Lymphoproliferative Disorders

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2012
Review
2012
Post transplant lymphoproliferative disorders: risk, classification, and therapeutic recommendations.
OPINION STATEMENT Post transplant lymphoproliferative disorder (PTLD) is a heterogeneous disease that may occur in recipients of… (More)
Is this relevant?
Review
2009
Review
2009
Post-transplant lymphoproliferative disorder.
BACKGROUND Posttransplant lymphoproliferative disorder (PTLD) is increasingly recognized as a serious complication of solid organ… (More)
  • table 1
Is this relevant?
Review
2007
Review
2007
Post-transplant lymphoproliferative disorder--the potential of proliferation signal inhibitors.
  • Julio Pascual
  • Nephrology, dialysis, transplantation : official…
  • 2007
Post-transplant lymphoproliferative disorder (PTLD) is a heterogeneous group of diseases characterized by abnormal lymphoid… (More)
Is this relevant?
Highly Cited
2006
Highly Cited
2006
Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: results of a prospective multicenter phase 2 study.
B-cell posttransplantation lymphoproliferative disorder (B-PTLD) is a rare but severe complication of transplantation, with no… (More)
Is this relevant?
Review
2005
Review
2005
Post-transplant lymphoproliferative disorders.
Post-transplant lymphoproliferative disorder (PTLD) is a life-threatening complication after hematopoietic stem cell or solid… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
Ganciclovir and acyclovir reduce the risk of post-transplant lymphoproliferative disorder in renal transplant recipients.
Given its association with Epstein-Barr virus (EBV), there is considerable interest in assessing the impact of prophylactic anti… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
Effect of anti-CD 20 antibody rituximab in patients with post-transplant lymphoproliferative disorder (PTLD).
Post-transplant lymphoproliferative disorders (PTLD) are a life-threatening complication following solid organ transplantation… (More)
Is this relevant?
Review
2005
Review
2005
Post-transplant lymphoproliferative disorder.
Post-transplant lymphoproliferative disorder (PTLD) is an increasingly recognized complication of solid organ and hematopoietic… (More)
Is this relevant?
Review
2001
Review
2001
Identifying the patient at risk for post-transplant lymphoproliferative disorder.
Post-transplant lymphoproliferative disorders (PTLD) are a recognized complication of the immunosuppression required to prevent… (More)
Is this relevant?
Highly Cited
1999
Highly Cited
1999
Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study.
We evaluated 18,014 patients who underwent allogeneic bone marrow transplantation (BMT) at 235 centers worldwide to examine the… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
  • table 4
Is this relevant?